Niya Emilova Semerdzhieva, Simeon Dimitrov, Adelina Tsakova, Mariana Gospodinova, Petar Atanasov, Vesela Lozanova
{"title":"急性冠状动脉综合征的标志物:经皮冠状动脉介入治疗时远端冠状动脉栓塞。","authors":"Niya Emilova Semerdzhieva, Simeon Dimitrov, Adelina Tsakova, Mariana Gospodinova, Petar Atanasov, Vesela Lozanova","doi":"10.3390/jcdd12080315","DOIUrl":null,"url":null,"abstract":"<p><p>(1) Introduction: Distal coronary emboli occur in up to 15-30.5% of patients undergoing percutaneous coronary intervention (PCI) for acute myocardial infarction (AMI) and are associated with poor myocardial reperfusion in the territory of the infarct-related artery. The objective of this study was to analyze the possible laboratory, clinical and imaging indicators of distal coronary embolism detected with an angiography at the time of PCI with stent implantation for acute coronary syndrome (ACS). (2) Methods: This analysis included 137 patients with ACS. The levels of cardiac enzymes (creatine kinase [CK], muscle-brain fraction of CK, high-sensitivity troponin T [hsTnT]), inflammatory markers (high-sensitivity C-reactive protein, white blood cell counts), sex steroids (total 17β-estradiol, total testosterone, dehydroepiandrosterone sulfate [DHEA-S]), serum lipids and oxidized low-density lipoproteins (oxLDL) were measured and analyzed for their relationship with the incidence of distal coronary embolism at PCI. (3) Results: Slow coronary blood flow was detected in the coronary artery subject to intervention in 9.4% (<i>n</i> = 13) of patients. Triglyceride (TG), high-density lipoprotein (HDL), glucose and serum DHEA-S levels were found to be associated with distal coronary embolization and slow coronary flow at PCI with stenting (DHEA-S: 1.316, OR 1.044-1.659, <i>p</i> = 0.020; TG: 1.130, OR 0.990-1.300, <i>p</i> = 0.072; HDL: 2.326, OR 0.918-5.8977, <i>p</i> = 0.075; glucose: 1.130, OR 0.990-1.300, <i>p</i> = 0.072). In the multivariable model, only DHEA-S after PCI tended to indicate a risk of distal coronary embolism (DHEA-S: <i>p</i> = 0.071; TG: <i>p</i> = 0.339; glucose: <i>p</i> = 0.582; HDL: <i>p</i> = 0.502). (4) Conclusions: Patients with ACS with higher triglyceride levels are at risk of developing slow blood flow after percutaneous intervention with stent implantation. Elevated DHEA-S possibly reflects sympathoadrenal and hypothalamus-pituitary-adrenal hyperactivity associated with ACS and coronary intervention.</p>","PeriodicalId":15197,"journal":{"name":"Journal of Cardiovascular Development and Disease","volume":"12 8","pages":""},"PeriodicalIF":2.3000,"publicationDate":"2025-08-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12386391/pdf/","citationCount":"0","resultStr":"{\"title\":\"Markers in Acute Coronary Syndrome: Distal Coronary Embolism at Percutaneous Coronary Intervention.\",\"authors\":\"Niya Emilova Semerdzhieva, Simeon Dimitrov, Adelina Tsakova, Mariana Gospodinova, Petar Atanasov, Vesela Lozanova\",\"doi\":\"10.3390/jcdd12080315\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>(1) Introduction: Distal coronary emboli occur in up to 15-30.5% of patients undergoing percutaneous coronary intervention (PCI) for acute myocardial infarction (AMI) and are associated with poor myocardial reperfusion in the territory of the infarct-related artery. The objective of this study was to analyze the possible laboratory, clinical and imaging indicators of distal coronary embolism detected with an angiography at the time of PCI with stent implantation for acute coronary syndrome (ACS). (2) Methods: This analysis included 137 patients with ACS. The levels of cardiac enzymes (creatine kinase [CK], muscle-brain fraction of CK, high-sensitivity troponin T [hsTnT]), inflammatory markers (high-sensitivity C-reactive protein, white blood cell counts), sex steroids (total 17β-estradiol, total testosterone, dehydroepiandrosterone sulfate [DHEA-S]), serum lipids and oxidized low-density lipoproteins (oxLDL) were measured and analyzed for their relationship with the incidence of distal coronary embolism at PCI. (3) Results: Slow coronary blood flow was detected in the coronary artery subject to intervention in 9.4% (<i>n</i> = 13) of patients. Triglyceride (TG), high-density lipoprotein (HDL), glucose and serum DHEA-S levels were found to be associated with distal coronary embolization and slow coronary flow at PCI with stenting (DHEA-S: 1.316, OR 1.044-1.659, <i>p</i> = 0.020; TG: 1.130, OR 0.990-1.300, <i>p</i> = 0.072; HDL: 2.326, OR 0.918-5.8977, <i>p</i> = 0.075; glucose: 1.130, OR 0.990-1.300, <i>p</i> = 0.072). In the multivariable model, only DHEA-S after PCI tended to indicate a risk of distal coronary embolism (DHEA-S: <i>p</i> = 0.071; TG: <i>p</i> = 0.339; glucose: <i>p</i> = 0.582; HDL: <i>p</i> = 0.502). (4) Conclusions: Patients with ACS with higher triglyceride levels are at risk of developing slow blood flow after percutaneous intervention with stent implantation. Elevated DHEA-S possibly reflects sympathoadrenal and hypothalamus-pituitary-adrenal hyperactivity associated with ACS and coronary intervention.</p>\",\"PeriodicalId\":15197,\"journal\":{\"name\":\"Journal of Cardiovascular Development and Disease\",\"volume\":\"12 8\",\"pages\":\"\"},\"PeriodicalIF\":2.3000,\"publicationDate\":\"2025-08-19\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12386391/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Cardiovascular Development and Disease\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.3390/jcdd12080315\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"CARDIAC & CARDIOVASCULAR SYSTEMS\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Cardiovascular Development and Disease","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3390/jcdd12080315","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0
摘要
(1)简介:在接受急性心肌梗死(AMI)经皮冠状动脉介入治疗(PCI)的患者中,远端冠状动脉栓塞发生率高达15-30.5%,并与梗死相关动脉区域心肌再灌注不良有关。本研究的目的是分析急性冠脉综合征(ACS)患者行PCI伴支架植入术时血管造影检测到远端冠状动脉栓塞可能的实验室、临床和影像学指标。(2)方法:对137例ACS患者进行分析。测量心肌酶(肌酸激酶[CK]、肌酸激酶的肌-脑部分、高敏肌钙蛋白T [hsTnT])、炎症标志物(高敏c反应蛋白、白细胞计数)、性类固醇(总17β-雌二醇、总睾酮、硫酸脱氢表雄酮[DHEA-S])、血脂和氧化低密度脂蛋白(oxLDL)水平,并分析其与PCI远端冠状动脉栓塞发生率的关系。(3)结果:9.4% (n = 13)的干预患者冠状动脉血流缓慢。甘油三酯(TG)、高密度脂蛋白(HDL)、葡萄糖和血清DHEA-S水平与PCI支架置入时远端冠状动脉栓塞和冠脉血流缓慢相关(DHEA-S: 1.316, OR 1.044-1.659, p = 0.020; TG: 1.130, OR 0.990-1.300, p = 0.072; HDL: 2.326, OR 0.918-5.8977, p = 0.075;葡萄糖:1.130,OR 0.990-1.300, p = 0.072)。在多变量模型中,PCI术后只有DHEA-S倾向于提示远端冠状动脉栓塞的风险(DHEA-S: p = 0.071; TG: p = 0.339;葡萄糖:p = 0.582; HDL: p = 0.502)。(4)结论:甘油三酯水平较高的ACS患者经皮介入支架置入术后存在血流缓慢的风险。DHEA-S升高可能反映了与ACS和冠状动脉介入治疗相关的交感肾上腺和下丘脑-垂体-肾上腺亢进。
Markers in Acute Coronary Syndrome: Distal Coronary Embolism at Percutaneous Coronary Intervention.
(1) Introduction: Distal coronary emboli occur in up to 15-30.5% of patients undergoing percutaneous coronary intervention (PCI) for acute myocardial infarction (AMI) and are associated with poor myocardial reperfusion in the territory of the infarct-related artery. The objective of this study was to analyze the possible laboratory, clinical and imaging indicators of distal coronary embolism detected with an angiography at the time of PCI with stent implantation for acute coronary syndrome (ACS). (2) Methods: This analysis included 137 patients with ACS. The levels of cardiac enzymes (creatine kinase [CK], muscle-brain fraction of CK, high-sensitivity troponin T [hsTnT]), inflammatory markers (high-sensitivity C-reactive protein, white blood cell counts), sex steroids (total 17β-estradiol, total testosterone, dehydroepiandrosterone sulfate [DHEA-S]), serum lipids and oxidized low-density lipoproteins (oxLDL) were measured and analyzed for their relationship with the incidence of distal coronary embolism at PCI. (3) Results: Slow coronary blood flow was detected in the coronary artery subject to intervention in 9.4% (n = 13) of patients. Triglyceride (TG), high-density lipoprotein (HDL), glucose and serum DHEA-S levels were found to be associated with distal coronary embolization and slow coronary flow at PCI with stenting (DHEA-S: 1.316, OR 1.044-1.659, p = 0.020; TG: 1.130, OR 0.990-1.300, p = 0.072; HDL: 2.326, OR 0.918-5.8977, p = 0.075; glucose: 1.130, OR 0.990-1.300, p = 0.072). In the multivariable model, only DHEA-S after PCI tended to indicate a risk of distal coronary embolism (DHEA-S: p = 0.071; TG: p = 0.339; glucose: p = 0.582; HDL: p = 0.502). (4) Conclusions: Patients with ACS with higher triglyceride levels are at risk of developing slow blood flow after percutaneous intervention with stent implantation. Elevated DHEA-S possibly reflects sympathoadrenal and hypothalamus-pituitary-adrenal hyperactivity associated with ACS and coronary intervention.